ClinicalTrials.govpublic full text
A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
breast cancer, breast neoplasms, 5-fluorouracil, cyclophosphamide, methotrexate, thiotepa, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813109
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.